168 related articles for article (PubMed ID: 35891525)
1. Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses.
Durán-Ferrer M; Villalba R; Fernández-Pacheco P; Tena-Tomás C; Jiménez-Clavero MÁ; Bouzada JA; Ruano MJ; Fernández-Pinero J; Arias M; Castillo-Olivares J; Agüero M
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891525
[TBL] [Abstract][Full Text] [Related]
2. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
4. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
[TBL] [Abstract][Full Text] [Related]
5. Immune response of horses to inactivated African horse sickness vaccines.
Rodríguez M; Joseph S; Pfeffer M; Raghavan R; Wernery U
BMC Vet Res; 2020 Sep; 16(1):322. PubMed ID: 32873300
[TBL] [Abstract][Full Text] [Related]
6. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.
Weyer CT; Grewar JD; Burger P; Joone C; Lourens C; MacLachlan NJ; Guthrie AJ
Vaccine; 2017 Apr; 35(18):2504-2510. PubMed ID: 28341113
[TBL] [Abstract][Full Text] [Related]
8. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
9. Development of a Microsphere-based Immunoassay for Serological Detection of African Horse Sickness Virus and Comparison with Other Diagnostic Techniques.
Sánchez-Matamoros A; Beck C; Kukielka D; Lecollinet S; Blaise-Boisseau S; Garnier A; Rueda P; Zientara S; Sánchez-Vizcaíno JM
Transbound Emerg Dis; 2016 Dec; 63(6):e270-e277. PubMed ID: 25693720
[TBL] [Abstract][Full Text] [Related]
10. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Maree S; Paweska JT
J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR
O'Kennedy MM; Coetzee P; Koekemoer O; du Plessis L; Lourens CW; Kwezi L; du Preez I; Mamputha S; Mokoena NB; Rutkowska DA; Verschoor JA; Lemmer Y
Vaccine; 2022 Aug; 40(35):5160-5169. PubMed ID: 35902279
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
[TBL] [Abstract][Full Text] [Related]
13. Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1.
Wang Y; Ong J; Ng OW; Songkasupa T; Koh EY; Wong JPS; Puangjinda K; Fernandez CJ; Huangfu T; Ng LC; Chang SF; Yap HH
Emerg Infect Dis; 2022 Dec; 28(12):2446-2454. PubMed ID: 36417933
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge.
Alberca B; Bachanek-Bankowska K; Cabana M; Calvo-Pinilla E; Viaplana E; Frost L; Gubbins S; Urniza A; Mertens P; Castillo-Olivares J
Vaccine; 2014 Jun; 32(29):3670-4. PubMed ID: 24837765
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
[TBL] [Abstract][Full Text] [Related]
16. Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.
Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
Antiviral Res; 2015 Apr; 116():27-33. PubMed ID: 25643968
[TBL] [Abstract][Full Text] [Related]
17. Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.
Lulla V; Lulla A; Wernike K; Aebischer A; Beer M; Roy P
J Virol; 2016 Aug; 90(16):7405-7414. PubMed ID: 27279609
[TBL] [Abstract][Full Text] [Related]
18. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
[TBL] [Abstract][Full Text] [Related]
19. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
von Teichman BF; Dungu B; Smit TK
Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
[TBL] [Abstract][Full Text] [Related]
20. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
